PF-02413873
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-02413873, covering 2010-02-10 to 2010-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women [Phase 1]